In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

ProStrakan will market Cellegy's Rectogesic in Europe

Executive Summary

Specialty pharma company ProStrakan Group (formed through the 2004 merger of Strakan Pharmaceuticals and ProSkelia) has taken on European marketing of a second product, Rectogesic, for partner Cellegy Pharmaceuticals.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • Intra-Biotech Deal
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register